Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel Free CTEC Stock Alerts

ConvaTec Group (CTEC) Competitors

ConvaTec Group logo
GBX 214.80 +0.60 (+0.28%)
As of 12:03 PM Eastern
Compare

CTEC vs. AMS, TSTL, SPEC, BVC, and AKR

Should you buy ConvaTec Group stock or one of its competitors? MarketBeat compares ConvaTec Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with ConvaTec Group include Advanced Medical Solutions Group (AMS), Tristel (TSTL), INSPECS Group (SPEC), BATM Advanced Communications (BVC), and Akers Biosciences (AKR). These companies are all part of the "medical instruments & supplies" industry.

How does ConvaTec Group compare to Advanced Medical Solutions Group?

ConvaTec Group (LON:CTEC) and Advanced Medical Solutions Group (LON:AMS) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability.

ConvaTec Group has a beta of 0.757, indicating that its stock price is 24% less volatile than the broader market. Comparatively, Advanced Medical Solutions Group has a beta of 0.701, indicating that its stock price is 30% less volatile than the broader market.

ConvaTec Group pays an annual dividend of GBX 6.77 per share and has a dividend yield of 3.2%. Advanced Medical Solutions Group pays an annual dividend of GBX 2.68 per share and has a dividend yield of 1.0%. ConvaTec Group pays out 78.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Advanced Medical Solutions Group pays out 59.3% of its earnings in the form of a dividend.

ConvaTec Group currently has a consensus target price of GBX 306, suggesting a potential upside of 42.46%. Advanced Medical Solutions Group has a consensus target price of GBX 270.25, suggesting a potential downside of 3.31%. Given ConvaTec Group's stronger consensus rating and higher possible upside, analysts clearly believe ConvaTec Group is more favorable than Advanced Medical Solutions Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ConvaTec Group
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89
Advanced Medical Solutions Group
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50

ConvaTec Group has higher revenue and earnings than Advanced Medical Solutions Group. ConvaTec Group is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ConvaTec Group£2.44B1.72£188.35M£8.6024.98
Advanced Medical Solutions Group£228.94M2.65£11.22M£4.5261.84

ConvaTec Group has a net margin of 7.17% compared to Advanced Medical Solutions Group's net margin of 4.35%. ConvaTec Group's return on equity of 10.53% beat Advanced Medical Solutions Group's return on equity.

Company Net Margins Return on Equity Return on Assets
ConvaTec Group7.17% 10.53% 5.01%
Advanced Medical Solutions Group 4.35%3.87%2.35%

68.2% of ConvaTec Group shares are held by institutional investors. Comparatively, 22.9% of Advanced Medical Solutions Group shares are held by institutional investors. 1.0% of ConvaTec Group shares are held by company insiders. Comparatively, 4.0% of Advanced Medical Solutions Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, ConvaTec Group's average media sentiment score of 0.00 equaled Advanced Medical Solutions Group'saverage media sentiment score.

Company Overall Sentiment
ConvaTec Group Neutral
Advanced Medical Solutions Group Neutral

Summary

ConvaTec Group beats Advanced Medical Solutions Group on 12 of the 16 factors compared between the two stocks.

How does ConvaTec Group compare to Tristel?

ConvaTec Group (LON:CTEC) and Tristel (LON:TSTL) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations.

68.2% of ConvaTec Group shares are owned by institutional investors. Comparatively, 21.6% of Tristel shares are owned by institutional investors. 1.0% of ConvaTec Group shares are owned by company insiders. Comparatively, 21.0% of Tristel shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

ConvaTec Group has a beta of 0.757, meaning that its share price is 24% less volatile than the broader market. Comparatively, Tristel has a beta of 0.339, meaning that its share price is 66% less volatile than the broader market.

ConvaTec Group pays an annual dividend of GBX 6.77 per share and has a dividend yield of 3.2%. Tristel pays an annual dividend of GBX 14.20 per share and has a dividend yield of 3.7%. ConvaTec Group pays out 78.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Tristel pays out 87.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Tristel has a net margin of 15.88% compared to ConvaTec Group's net margin of 7.17%. Tristel's return on equity of 23.64% beat ConvaTec Group's return on equity.

Company Net Margins Return on Equity Return on Assets
ConvaTec Group7.17% 10.53% 5.01%
Tristel 15.88%23.64%9.89%

ConvaTec Group presently has a consensus target price of GBX 306, suggesting a potential upside of 42.46%. Given ConvaTec Group's stronger consensus rating and higher possible upside, equities analysts plainly believe ConvaTec Group is more favorable than Tristel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ConvaTec Group
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89
Tristel
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Tristel had 1 more articles in the media than ConvaTec Group. MarketBeat recorded 1 mentions for Tristel and 0 mentions for ConvaTec Group. ConvaTec Group's average media sentiment score of 0.00 equaled Tristel'saverage media sentiment score.

Company Overall Sentiment
ConvaTec Group Neutral
Tristel Neutral

ConvaTec Group has higher revenue and earnings than Tristel. Tristel is trading at a lower price-to-earnings ratio than ConvaTec Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ConvaTec Group£2.44B1.72£188.35M£8.6024.98
Tristel£49.54M3.73£6.54M£16.2423.71

Summary

ConvaTec Group beats Tristel on 9 of the 17 factors compared between the two stocks.

How does ConvaTec Group compare to INSPECS Group?

INSPECS Group (LON:SPEC) and ConvaTec Group (LON:CTEC) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, profitability, valuation, risk and institutional ownership.

INSPECS Group has a beta of 1.607, meaning that its stock price is 61% more volatile than the broader market. Comparatively, ConvaTec Group has a beta of 0.757, meaning that its stock price is 24% less volatile than the broader market.

ConvaTec Group has a net margin of 7.17% compared to INSPECS Group's net margin of -2.67%. ConvaTec Group's return on equity of 10.53% beat INSPECS Group's return on equity.

Company Net Margins Return on Equity Return on Assets
INSPECS Group-2.67% -6.07% 0.45%
ConvaTec Group 7.17%10.53%5.01%

In the previous week, INSPECS Group's average media sentiment score of 0.00 equaled ConvaTec Group'saverage media sentiment score.

Company Overall Sentiment
INSPECS Group Neutral
ConvaTec Group Neutral

0.4% of INSPECS Group shares are owned by institutional investors. Comparatively, 68.2% of ConvaTec Group shares are owned by institutional investors. 19.6% of INSPECS Group shares are owned by company insiders. Comparatively, 1.0% of ConvaTec Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

ConvaTec Group has higher revenue and earnings than INSPECS Group. INSPECS Group is trading at a lower price-to-earnings ratio than ConvaTec Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
INSPECS Group£191.70M0.54-£4.11M-£9.40N/A
ConvaTec Group£2.44B1.72£188.35M£8.6024.98

INSPECS Group currently has a consensus target price of GBX 60, indicating a potential downside of 36.84%. ConvaTec Group has a consensus target price of GBX 306, indicating a potential upside of 42.46%. Given ConvaTec Group's higher probable upside, analysts clearly believe ConvaTec Group is more favorable than INSPECS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
INSPECS Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
ConvaTec Group
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89

Summary

ConvaTec Group beats INSPECS Group on 11 of the 14 factors compared between the two stocks.

How does ConvaTec Group compare to BATM Advanced Communications?

ConvaTec Group (LON:CTEC) and BATM Advanced Communications (LON:BVC) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership.

ConvaTec Group presently has a consensus price target of GBX 306, indicating a potential upside of 42.46%. Given ConvaTec Group's stronger consensus rating and higher probable upside, equities analysts plainly believe ConvaTec Group is more favorable than BATM Advanced Communications.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ConvaTec Group
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

ConvaTec Group has a beta of 0.757, indicating that its share price is 24% less volatile than the broader market. Comparatively, BATM Advanced Communications has a beta of 0.754, indicating that its share price is 25% less volatile than the broader market.

68.2% of ConvaTec Group shares are held by institutional investors. Comparatively, 16.6% of BATM Advanced Communications shares are held by institutional investors. 1.0% of ConvaTec Group shares are held by insiders. Comparatively, 31.0% of BATM Advanced Communications shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

ConvaTec Group has a net margin of 7.17% compared to BATM Advanced Communications' net margin of -14.90%. ConvaTec Group's return on equity of 10.53% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
ConvaTec Group7.17% 10.53% 5.01%
BATM Advanced Communications -14.90%-22.13%0.58%

In the previous week, BATM Advanced Communications had 1 more articles in the media than ConvaTec Group. MarketBeat recorded 1 mentions for BATM Advanced Communications and 0 mentions for ConvaTec Group. BATM Advanced Communications' average media sentiment score of 0.28 beat ConvaTec Group's score of 0.00 indicating that BATM Advanced Communications is being referred to more favorably in the news media.

Company Overall Sentiment
ConvaTec Group Neutral
BATM Advanced Communications Neutral

ConvaTec Group has higher revenue and earnings than BATM Advanced Communications. BATM Advanced Communications is trading at a lower price-to-earnings ratio than ConvaTec Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ConvaTec Group£2.44B1.72£188.35M£8.6024.98
BATM Advanced Communications£123.20M0.40-£278.26K-£4.20N/A

Summary

ConvaTec Group beats BATM Advanced Communications on 13 of the 16 factors compared between the two stocks.

How does ConvaTec Group compare to Akers Biosciences?

ConvaTec Group (LON:CTEC) and Akers Biosciences (LON:AKR) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, analyst recommendations, institutional ownership, profitability, valuation and risk.

ConvaTec Group has higher revenue and earnings than Akers Biosciences. Akers Biosciences is trading at a lower price-to-earnings ratio than ConvaTec Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ConvaTec Group£2.44B1.72£188.35M£8.6024.98
Akers Biosciences£2.32M0.00N/A-£129.60N/A

68.2% of ConvaTec Group shares are held by institutional investors. 1.0% of ConvaTec Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

ConvaTec Group presently has a consensus price target of GBX 306, suggesting a potential upside of 42.46%. Given ConvaTec Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe ConvaTec Group is more favorable than Akers Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ConvaTec Group
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.89
Akers Biosciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

ConvaTec Group has a net margin of 7.17% compared to Akers Biosciences' net margin of 0.00%. ConvaTec Group's return on equity of 10.53% beat Akers Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
ConvaTec Group7.17% 10.53% 5.01%
Akers Biosciences N/A N/A N/A

In the previous week, Akers Biosciences had 1 more articles in the media than ConvaTec Group. MarketBeat recorded 1 mentions for Akers Biosciences and 0 mentions for ConvaTec Group. ConvaTec Group's average media sentiment score of 0.00 beat Akers Biosciences' score of -1.14 indicating that ConvaTec Group is being referred to more favorably in the media.

Company Overall Sentiment
ConvaTec Group Neutral
Akers Biosciences Negative

Summary

ConvaTec Group beats Akers Biosciences on 12 of the 13 factors compared between the two stocks.

Get ConvaTec Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for CTEC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CTEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CTEC vs. The Competition

Export
MetricConvaTec GroupMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£4.20B£3.02B£7.06B£2.78B
Dividend Yield2.52%1.91%2.68%6.17%
P/E Ratio24.9817.4922.37368.18
Price / Sales1.72107.81526.8984,613.91
Price / Cash17.01146.5429.2227.87
Price / Book2.682.5410.757.49
Net Income£188.35M£99.80M£3.58B£5.89B
7 Day Performance-4.70%0.99%-2.10%-0.48%
1 Month Performance6.02%3.65%3.32%-1.00%
1 Year Performance-17.64%-5.72%28.17%61.74%

ConvaTec Group Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CTEC
ConvaTec Group
4.5023 of 5 stars		GBX 214.80
+0.3%		GBX 306
+42.5%		-17.9%£4.20B£2.44B24.9810,000
AMS
Advanced Medical Solutions Group
N/AGBX 278.50
-0.4%		GBX 270.25
-3.0%		+36.2%£605.42M£228.94M61.6210
TSTL
Tristel
N/AGBX 395.20
+1.3%		GBX 400
+1.2%		-6.5%£189.68M£49.54M24.33208
SPEC
INSPECS Group
N/AGBX 100
+3.1%		GBX 60
-40.0%		+107.8%£109.18M£191.70MN/A1,673
BVC
BATM Advanced Communications
N/AGBX 14.25
-5.0%		N/A-4.3%£48.46M£123.20MN/A980

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:CTEC) was last updated on 7/13/2026 by MarketBeat.com Staff.
From Our Partners
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel
I paid $5,000 to hear Elon say this
One investor paid $5,000 to be in a private room with Elon Musk in Los Angeles - and what he heard confirmed a...
InvestorPlace | Sponsoredtc pixel